November 7, 2020 – 1:22 pm
This new video is a composite of video clips from different patients which best illustrate the techniques I use to perform an open abdominal myomectomy. The first video clip is the surgery for a woman with a very large, 10 inch, fibroid. She had been seen by 5 gynecologists, each of whom had told her […]
February 17, 2020 – 5:55 pm
Dr. Parker was invited to give a lecture at the MIT Science and Medicine Forum in October. Speakers were asked to choose “anything you want to talk about.” The audience was made up of MIT basic science researchers, medical doctors, and hospital administrators. I chose “Myomectomy, not Hysterectomy,” a topic that dominates my practice and […]
Dr. Parker has just written an article for OBG Management, a free OB-Gyn journal with the largest number of readers of all the OB-Gyn journals. In this article, Dr. Parker debunks the myths that gynecologists have been taught about myomectomy and the myths that women are often told as the reasons why they should have […]
January 29, 2016 – 11:42 pm
Jeffrey Shuren, M.D., J.D., the Director of the Center for Device and Radiological Health at the Food and Drug Administration, replied to an open letter from the Leiomyoma Morcellation Review Group. You can read the original open letter here, and view Dr. Shuren’s reply in the images below. The Leiomyoma Morcellation Review Group sent the […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopic myomectomy, laparoscopy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, ovarian cancer, power morcellation, power morcellator
|
December 8, 2015 – 5:00 pm
In November, 2014 the FDA ruled that power morcellation was contra-indicated in “the majority of women” having surgery for uterine fibroids due to the potential risk of spreading occult uterine sarcoma. Although problems with this ruling were immediately apparent, the passage of time has allowed for more clarity on the related medical issues. Prevalence of […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopic myomectomy, laparoscopy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, no hysterectomy, ovarian cancer, power morcellation, power morcellator
|
Joan, San Diego I’ve been feeling frustrated and concerned about the upcoming FDA meeting later this week on the power morcellator. My fear is that the FDA panel will get a very slanted view of the situation because not enough woman who have benefited from minimally invasive gyn surgery using a morcellator can take the […]
By Bill Parker, MD
|
Posted in Recent Fibroid Research
|
Also tagged FDA, fibroids, focused ultrasound, Gynecologic Surgery, HIFU, hysteroscopic myomectomy, laparoscopic hysterectomy, laparoscopic myomectomy, minimally invasive surgery, Morcellation, morcellator, supra-cervial hysterectomy, UAE, uterine artery embolization
|
August 10, 2009 – 3:04 pm
Good surgical technique and adhesion barriers decreases the risk of adhesions (scar tissue) after abdominal myomectomy
August 10, 2009 – 2:13 pm
Choosing the right doctor for your fibroid surgery – Laparoscopic Myomectomy, Robotic Myomectomy or Abdominal Myomectomy
Dr. Parker’s Comment: I recently attended a lecture by a world expert in blood transfusion medicine and it was eye-opening. It turns out that every day that blood, even your own blood, sits in the blood bank refrigerator, it decreases in quality. Studies show that in an ICU with really ill patients, the ones who […]
Disclaimer: The ideas, procedures and suggestions contained on this web site are not intended as a substitute for consulting with your physician. All matters regarding your health require medical supervision.